A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT06976190 · RECRUITING
Trial details
- NCT number
- NCT06976190
- Sponsor
- Shanghai Miracogen Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-06
- Primary completion
- 2029-05-01
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.